United States. Securities and Exchange Commission
A U.S. Securities and Exchange Commission filing by Xoma Corp. was submitted on May 22, 2015, through Form 4, which is a document that discloses the ownership stakes of directors, officers, or shareholders with more than 10% equity in a company. The filing, with the SEC file number 0000791908-15-000065,
United States. Securities and Exchange Commission
Western Gas Equity Partners, Lp, a natural gas transmission company, filed a Form 4 with the U.S. Securities and Exchange Commission (SEC) on May 14, 2015. The Form 4 filing provides information on purchases and sales of equity securities by the company's directors, officers, and owners of
United States. Securities and Exchange Commission
Energy Transfer Partners, L.P, a Delaware-based entity, has filed a Current Report (FORM 8-K) with the Securities and Exchange Commission on June 01, 2015. The report relates to the company's acquisition of Regency Energy Partners LP and the subsequent agreement to guarantee payment obligations under a $600.
United States. Securities and Exchange Commission
Seattle Genetics Inc. has recently filed a U.S. Securities and Exchange Commission (SEC) form SC 13D, disclosing beneficial ownership of certain registered equity securities. This filing, posted on May 8, 2015, provides essential information about the company's equity holdings. As a biotechnology company specializing in biological products,
United States. Securities and Exchange Commission
Avalanche Biotechnologies, a biotechnology company with a focus on biological products, filed a Form 4 document with the U.S. Securities and Exchange Commission (SEC) on May 7, 2015. The filing provided insights into the company's equity securities and the relationship between its directors, officers, and major shareholders.
United States. Securities and Exchange Commission
Teleflex Incorporated, a Delaware-based company, filed a Form 8-K with the Securities and Exchange Commission on May 21, 2015, announcing its longer-term financial goals and objectives, which it planned to discuss later that day during its investor and analyst conference. The company reaffirmed its previously provided 2015 constant currency revenue
United States. Securities and Exchange Commission
Boston Scientific Corp. has recently submitted a U.S. Securities and Exchange Commission (SEC) filing, detailing its financial performance for the first fiscal quarter of the year. The company, a leading developer and manufacturer of minimally invasive medical devices, provided an unaudited financial statement in the Form 10-Q filing. The
United States. Securities and Exchange Commission
Apache Corp., a leading U.S. energy company, recently filed a document with the Securities and Exchange Commission (SEC) on April 22, 2015. The filing, designated as Form 4, provides information on the company's ownership structure and transactions involving its equity securities. As a publicly-traded company, Apache Corp.
United States. Securities and Exchange Commission
Helix Energy Solutions Group, Inc. has announced the delivery of the Q5000 semisubmersible well intervention vessel from Sembcorp Marine's Jurong Shipyard to its wholly owned subsidiary, Helix Q5000 Holdings S.A.R.L. The vessel was delivered on April 30th, and in conjunction with the delivery, Helix Q5000
United States. Securities and Exchange Commission
A recent U.S. Securities and Exchange Commission filing by Sigma Designs Inc. (Form 8-K) has revealed key information about the company's corporate changes and material events. The filing, made on April 14, 2015, provides insight into the company's current status and recent developments. This form
United States. Securities and Exchange Commission
According to a U.S. Securities and Exchange Commission (SEC) filing, Applied Optoelectronics, Inc. reported material events and corporate changes on April 13, 2015. The company, classified under the SIC code 3674 (Semiconductors and Related Devices), filed three documents with the SEC. The contact information for Applied Optoelectronics, Inc. is
United States. Securities and Exchange Commission
Sciclone Pharmaceuticals Inc. has reported a material event to the Securities and Exchange Commission (SEC) in the form of a Form 8-K filing, dated April 6, 2015. As a pharmaceutical company under the SIC code 2834, this filing is a critical document for investors and security holders, providing current information
